Characteristics on Drug Safety Measures in Japan Stratified by System Organ Classes and Therapeutic Categories in Relation to the Approval Date.

Therapeutic Innovation & Regulatory Science
Ayaka HiramatsuYoshiaki Uyama

Abstract

Revisions of drug package inserts (PIs) may be made immediately after approval or after considerable clinical experience; however, it is unclear whether there is a relationship between the characteristics of these safety measures and the period since drug approval. Here, we analyzed 209 cases of safety measures (revisions of the PIs) taken in Japan over 5 years (FY2014 to FY2018). The median, minimum, and maximum period from approval date in Japan to PI revision date was 6.29 years (interquartile range 2.68-15.53 years), 0.16 years, and 59.69 years, respectively. The cases were classified into four groups depending on types of adverse reaction and therapeutic category in relation to the national approval date and international birth date, resulting in the grouping together of particular adverse reactions and therapeutic drugs. For example, "Hepatobiliary disorders", "Blood and lymphatic system disorders", "Respiratory, thoracic and mediastinal disorders", "Antineoplastics", "Chemotherapeutics", and "Other agents affecting metabolism" were associated with the group of safety measures taken early after approval of a drug soon after the international birth date, suggesting that careful attention at an earlier stage after approval ...Continue Reading

References

Dec 14, 1995·The New England Journal of Medicine·J C RoujeauF Locati
Feb 13, 2001·Journal of Cutaneous Pathology·A SidoroffJ C Roujeau
Jul 16, 2010·Journal of Clinical Pharmacology·Kae NakashimaMasahiro Takeuchi
Jan 3, 2013·Pharmacoepidemiology and Drug Safety·Jean LesterGerald Dal Pan
Nov 28, 2013·Clinical Pharmacology and Therapeutics·F L ArnoldS Ono
Apr 1, 2014·Clinical Journal of Gastroenterology·Kazuhiko MoriHiromu Kutsumi
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Jul 20, 2017·Pharmacoepidemiology and Drug Safety·Chieko IshiguroTadashi Izawa
Oct 24, 2017·Pharmaceutical Medicine·Makoto Fujikawa, Shunsuke Ono
Nov 16, 2017·Clinical and Translational Science·Kunihito AsanoMasahiro Tohkin
Nov 7, 2019·Therapeutic Innovation & Regulatory Science·Shray Bablani, Manthan D Janodia

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
H GeldenhuysM Hatherill
Pharmacoepidemiology and Drug Safety
Maryann Mazer-AmirshahiLouis Cantilena
Cancer Treatment and Research
Abigail K R Lytton-JeanRobert Langer
© 2022 Meta ULC. All rights reserved